Met Life Investment Management, LLC Talaris Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 10, 2024	BUY	$4.51 - $9.85 $62,792 - $137,141	13,923 New	13,923 $62,000
Q2 2022 Jun 20, 2023	BUY	$4.51 - $9.85 $62,792 - $137,141	13,923 New	13,923 $62,000
Q2 2022 Mar 22, 2023	BUY	$4.51 - $9.85 $18,766 - $40,985	4,161 Added 42.62%	13,923 $62,000
Q2 2022 Aug 11, 2022	BUY	$4.51 - $9.85 $62,792 - $137,141	13,923 New	13,923 $63,000
Q1 2022 May 12, 2022	SELL	$6.89 - $16.56 $67,260 - $161,658	-9,762 Closed	0 $0
Q4 2021 May 17, 2024	BUY	$12.18 - $17.0 $118,901 - $165,954	9,762 New	9,762 $149,000
Q4 2021 Jun 21, 2023	BUY	$12.18 - $17.0 $118,901 - $165,954	9,762 New	9,762 $149,000
Q4 2021 Mar 22, 2023	BUY	$12.18 - $17.0 $118,901 - $165,954	9,762 New	9,762 $149,000
Q4 2021 Feb 15, 2022	BUY	$12.18 - $17.0 $118,901 - $165,954	9,762 New	9,762 $149,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.